Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #3683
Reference
Drug alert no 05/2011
Name
Drug alert no 5: class 4 [AstraZeneca UK - Pulmicort CFC–free Inhaler]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
AstraZeneca UK Ltd has discontinued production of the Pulmicort CFC–free Inhaler 100 and 200 micrograms and NebuChamber Spacer, with immediate effect, due to complex manufacturing issues.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Pharmacy Division, Primary and Community Care Directorate, St Andrew’s House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2011-03-09 00:00:00
Click to go back to homepage